MEDIA

COMMUNIQUE DE PRESSE

IN THE NEWS

11/05/2017

GAL 9 : Nouvelle cible first-in class en immuno-oncologie.

Read more

H-IMMUNE A BENEFICIE DE 30 K€ DE LA PART DE MATWIN

IN THE PRESS

10/05/2017

To read the article, please click here

Read more

STRATEGIC RESEARCH PARTNERSHIP

PRESS RELEASE

20/03/2017

Pierre Fabre and H-Immune announce strategic research partnership to develop potentially ground-breaking cancer immunotherapies.

Read more


back to top